Key result
Catheter ablation before ASD closure linked to ~46-point lower AF recurrence vs no ablation.
Why the study?
Few studies had investigated the efficacy of catheter ablation in patients with paroxysmal AF and ASD.
Does catheter ablation before ASD device closure improve AF-free survival in patients with paroxysmal AF and ASD?
Cohort (n=116)
Yes
Does catheter ablation before ASD device closure improve AF-free survival in patients with paroxysmal AF and ASD?
Catheter ablation performed prior to ASD device closure is an effective strategy for maintaining sinus rhythm in patients with paroxysmal AF and ASD.
Answers are grounded in this paper and cite their sources.
Supports pre-closure ablation in paroxysmal AF with ASD; hypothesis-generating and requires randomized confirmation before practice change.
AbstractIntroductionGiven that few studies investigated the efficacy of catheter ablation (CA) in patients with paroxysmal atrial fibrillation (AF) and atrial septal defect (ASD), this study evaluated its effectiveness in patients with paroxysmal AF and ASD.Methods and ResultsOf the 216 patients who underwent ASD device closure at two hospitals, 36 patients had paroxysmal AF. After April 2012, CA for AF was performed before ASD device closure (ASD‐CA group; n = 20). The ASD‐CA group had a significantly higher AF‐free survival rate after ASD device closure compared to patients without CA for AF before ASD device closure (ASD‐non‐CA group; n = 16) (ASD‐CA group: 2 patients vs. ASD‐non‐CA group: 9 patients; follow‐up period: 4.2 ± 2.5 years; log‐rank p = .01). In addition, the AF‐free survival rates were similar between the ASD‐CA group and 80 paroxysmal AF patients who underwent CA without any detectable structural heart disease (non‐SHD‐CA group). The two groups were matched by propensity scores for age, sex, and left atrium dimension (ASD‐CA group: 2 patients vs. non‐SHD‐CA group: 5 patients; follow‐up period: 3.3 ± 1.8 years; log‐rank p = .28).ConclusionCA for AF before ASD device closure might be an effective treatment option for patients with paroxysmal AF and ASD.
No takes yet. Share an insight, caveat, or question.
Ogiso et al. (2020) conducted a cohort in Paroxysmal atrial fibrillation and atrial septal defect (n=116). Catheter ablation before ASD device closure vs. No catheter ablation before ASD device closure was evaluated on Atrial fibrillation-free survival (AF recurrence) (p=.01). Catheter ablation prior to atrial septal defect closure improved atrial fibrillation-free survival compared to no ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: